KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Total Debt (2016 - 2025)

Historic Total Debt for Pacira BioSciences (PCRX) over the last 15 years, with Q3 2025 value amounting to $376.7 million.

  • Pacira BioSciences' Total Debt rose 2211.77% to $376.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $376.7 million, marking a year-over-year increase of 2211.77%. This contributed to the annual value of $585.3 million for FY2024, which is 37263.15% up from last year.
  • According to the latest figures from Q3 2025, Pacira BioSciences' Total Debt is $376.7 million, which was up 2211.77% from $300.2 million recorded in Q2 2025.
  • Pacira BioSciences' 5-year Total Debt high stood at $685.7 million for Q4 2021, and its period low was $109.8 million during Q2 2024.
  • Its 5-year average for Total Debt is $277.0 million, with a median of $284.7 million in 2022.
  • In the last 5 years, Pacira BioSciences' Total Debt tumbled by 6951.96% in 2023 and then soared by 37263.15% in 2024.
  • Over the past 5 years, Pacira BioSciences' Total Debt (Quarter) stood at $685.7 million in 2021, then plummeted by 58.48% to $284.7 million in 2022, then plummeted by 56.5% to $123.8 million in 2023, then soared by 372.63% to $585.3 million in 2024, then crashed by 35.64% to $376.7 million in 2025.
  • Its Total Debt stands at $376.7 million for Q3 2025, versus $300.2 million for Q2 2025 and $303.6 million for Q1 2025.